Groowe Groowe / Newsroom / REGN
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

REGN News

Regeneron Pharmaceuticals Inc

REGN Stockholders Have Rights – If You Lost Money Investing in Regeneron Pharmaceuticals, Inc. Contact Robbins LLP for Information About Recovering Your Losses

globenewswire.com
REGN

Contact Levi & Korsinsky by September 14, 2026 to Join Class Action Against Regeneron Pharmaceuticals, Inc. (REGN)

accessnewswire.com
REGN

Investors Urged to Contact Levi & Korsinsky For Information Before September 14, 2026 - Regeneron Pharmaceuticals, Inc. (REGN)

accessnewswire.com
REGN

Shareholders of Regeneron Pharmaceuticals, Inc. (REGN): Protect Your Rights Before September 14, 2026 - Contact Levi & Korsinsky

accessnewswire.com
REGN

Pomerantz LLP Advises Shareholders of Class Action Against Regeneron Pharmaceuticals, Inc. – REGN

accessnewswire.com
REGN

$REGN Stock News: Regeneron Securities Class Action is Pending - Investors Are Notified to Protect Your Rights

accessnewswire.com
REGN

REGN INVESTOR ALERT: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Regeneron Class Action Lawsuit - Hagens Berman

prnewswire.com
REGN

REGN ALERT: Securities Fraud Class Action Launched Against Regeneron Pharmaceuticals, Inc. - September 14, 2026 Deadline

accessnewswire.com
REGN

Bronstein, Gewirtz & Grossman LLC Urges Regeneron Pharmaceuticals, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

globenewswire.com
REGN

Investor Alert: Deadline Approaching to Join Regeneron Pharmaceuticals, Inc. (REGN) Class Action - Contact Levi & Korsinsky

accessnewswire.com
REGN